查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1666179

全球醫療分析市場 - 2025 至 2033 年

Global Healthcare Analytics Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球醫療保健分析市場規模達到 297.3 億美元，預計到 2033 年將達到 479.7 億美元，在 2025-2033 年預測期內的複合年成長率為 5.4%。

醫療保健分析是一種分析大量醫療保健資料以改善決策和結果的方法。它使用描述性、預測性和規範性分析等工具將來自 EHR、醫學影像和患者監測系統等來源的原始資料轉換為可操作的見解。醫療保健分析可最佳化患者護理、提高營運效率、降低成本並支持基於證據的決策。它使用巨量資料、人工智慧和機器學習來改善結果同時最大限度地降低風險。

市場動態：

促進因素與約束因素

醫療保健領域擴大採用數據驅動的決策

全球醫療保健分析市場的發展受到醫療保健產業日益採用數據驅動決策的推動。醫療保健組織（包括醫院、付款人和製藥公司）正在使用分析來提高營運效率、加強患者護理並降低成本。隨著醫療保健資料量的不斷成長，分析解決方案可以實現預測分析，以識別健康趨勢、風險和治療結果。這有助於醫療保健提供者做出明智的決策，從而獲得更好的臨床和財務結果。政府和醫療保健組織正在投資醫療保健數位化和資料基礎設施，進一步支持醫療保健分析市場的成長。

例如，2024 年 8 月，領先的醫療保健 AI 公司 Innovaccer Inc. 推出了政府健康 AI 數據和分析平台 (GHAAP)，這是一個屢獲殊榮的公共部門平台。該平台專注於醫療補助和公共衛生現代化，連續三年被 KLAS Research 和 Black Book 評為人口健康領域的頂級資料和分析平台。

資料隱私和安全問題

醫療保健分析解決方案通常涉及收集和處理大量患者資料，這可能導致資料外洩和未經授權的存取。這對患者的隱私和信任構成了嚴重風險。醫療保健組織必須遵守 HIPAA 和 GDPR 等嚴格的監管要求，這增加了資料管理的複雜性。這些法規要求採取強力的安全措施，這可能會花費大量成本且耗費時間。因此，對病患資料安全性和保密性的擔憂可能會阻礙醫療保健分析的廣泛採用，尤其是在資料保護基礎設施較不成熟的地區。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 醫療保健領域擴大採用數據驅動的決策
    • 限制
      • 資料隱私和安全問題
    • 機會
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：按組件

  • 軟體
  • 服務

第 7 章：按類型

  • 描述性分析
  • 預測分析
  • 規範分析

第 8 章：按應用

  • 財務分析
  • 臨床分析
  • 營運分析
  • 人口健康分析
  • 其他

第 9 章：按最終用戶

  • 醫院和醫療保健提供者
  • 醫療付款人（保險公司）
  • 製藥及生技公司
  • 政府組織

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • IBM Corporation
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • SAS Institute Inc.
  • McKesson Corporation
  • HR Insights
  • Siemens Healthineers
  • Oracle Corporation
  • Allscripts Healthcare Solutions, Inc.
  • Philips Healthcare
  • IQVIA
  • Flatiron Health
  • Similar data will be provided for each market player.
  • 健康催化劑
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • Verisk 分析
  • 奧姆尼系統
  • 將為每個市場參與者提供類似的資料。

第 13 章：附錄

簡介目錄
Product Code: HCIT250

The Global Healthcare Analytics Market reached US$ 29.73 Billion in 2024 and is expected to reach US$ 47.97 Billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.

Healthcare Analytics is a method of analyzing large amounts of healthcare data to improve decision-making and outcomes. It uses tools like descriptive, predictive, and prescriptive analytics to transform raw data from sources like EHRs, medical imaging, and patient monitoring systems into actionable insights. Healthcare analytics optimizes patient care, enhances operational efficiency, reduces costs, and supports evidence-based decision-making. It uses big data, AI, and machine learning to improve outcomes while minimizing risks.

Market Dynamics: Drivers & Restraints

Increasing Adoption of Data-driven Decision Making in Healthcare

The Global Healthcare Analytics Market is driven by the growing adoption of data-driven decision making in the healthcare industry. Healthcare organizations, including hospitals, payers, and pharmaceutical companies, are using analytics to improve operational efficiencies, enhance patient care, and reduce costs. With the growing volume of healthcare data, analytics solutions enable predictive analysis to identify health trends, risks, and treatment outcomes. This helps healthcare providers make informed decisions, leading to better clinical and financial outcomes. Governments and healthcare organizations are investing in healthcare digitization and data infrastructure, further supporting the growth of the healthcare analytics market.

For instance, in August 2024, Innovaccer Inc., a leading healthcare AI company, has launched the Government Health AI Data and Analytics Platform (GHAAP), an award-winning platform for the public sector. The platform focuses on Medicaid and Public Health Modernization and has been ranked as the top data and analytics platform for Population Health by KLAS Research and Black Book three years in a row.

Data Privacy and Security Concerns

Healthcare analytics solutions often involve the collection and processing of large volumes of patient data, which can lead to data breaches and unauthorized access. This poses serious risks to patient privacy and trust. Healthcare organizations must comply with stringent regulatory requirements like HIPAA and GDPR, adding complexity to data management. These regulations require robust security measures, which can be costly and time-consuming. As a result, concerns over the security and confidentiality of patient data can hinder the widespread adoption of healthcare analytics, especially in regions with less mature data protection infrastructure.

Segment Analysis

The global healthcare analytics market is segmented based on Component, Type, Application, End User and Region.

Component:

Software segment is expected to dominate the Healthcare Analytics market share

The software segment holds a major portion of the Healthcare Analytics market share and is expected to continue to hold a significant portion of the Healthcare Analytics market share during the forecast period.

The Global Healthcare Analytics Market is dominated by software solutions that collect, process, and analyze vast amounts of healthcare data. These tools enable organizations to perform descriptive, predictive, and prescriptive analytics, providing insights to improve patient care, reduce operational costs, and enhance clinical decision-making. Key software solutions include EHR management tools, CDSS, and patient monitoring systems. As healthcare providers adopt data-driven strategies, software solutions are becoming indispensable in improving healthcare efficiency and patient outcomes, driving market growth.

For instance, in May 2024, Health Catalyst has launched Health Catalyst Ignite, a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in a modern environment.

End User:-

Hospitals and Healthcare Providers segment is the fastest-growing segment in Healthcare Analytics market share

The hospitals and healthcare providers segment is the fastest-growing segment in the Healthcare Analytics market share and is expected to hold the market share over the forecast period.

The Hospitals & Healthcare Providers segment is driving the Global Healthcare Analytics Market due to the need to improve patient care, operational efficiency, and reduce costs. Healthcare providers are adopting analytics solutions to gain data-driven insights, optimize treatment pathways, and manage resources effectively. The rising prevalence of chronic diseases and growing patient population are driving the need for predictive and prescriptive analytics. The increasing volume of healthcare data from EHRs and medical devices is also driving the need for advanced data analytics tools. Population health management strategies are also driving market growth.

For instance, in October 2024, Growth.Health has launched the G1 Healthcare Data and Analytics Platform, a SaaS engine designed to provide unprecedented insights into the healthcare industry. The platform will be publicly unveiled at HLTH 2024 in Las Vegas, allowing professionals to better understand their customers and identify similar individuals.

Geographical Analysis

North America is expected to hold a significant position in the Healthcare Analytics market share

North America holds a substantial position in the Healthcare Analytics market and is expected to hold most of the market share due to high healthcare spending, and strong technological adoption. Also the region's well-established healthcare system and health tech ecosystem are fuelled by the widespread use of EHRs and cloud-based analytics solutions. The growing prevalence of chronic diseases and focus on value-based care are driving demand for efficient patient care and data management solutions. With supportive government initiatives and a favourable regulatory environment, North America is poised to continue its leadership role in the healthcare analytics market.

For instance, in January 2025, LexisNexis Risk Solutions has launched research-ready real-world datasets to accelerate research timelines, reduce costs, and enable more equitable analyses. These datasets are blended, expertly determined, and certified using referential-based tokenization. This simplifies data enrichment and cohort definition, allowing research teams to benchmark with comparator cohorts. These datasets integrate into clinical research workflows, generating real-world evidence to accelerate innovation and speed-to-market.

Europe is growing at the fastest pace in the Healthcare Analytics market

Europe holds the fastest pace in the Healthcare Analytics market and is expected to hold most of the market share due to government-backed digitization initiatives, increasing demand for data-driven healthcare solutions, and an aging population. Countries are investing in eHealth and health IT systems to improve healthcare delivery, reduce inefficiencies, and enhance patient outcomes. Telemedicine and remote patient monitoring technologies are also contributing to the demand for analytics. Strong regulatory frameworks like GDPR prioritize data privacy and security, making Europe a strong contributor to the market.

Competitive Landscape

The major global players in the Healthcare Analytics market include IBM Corporation, SAS Institute Inc. McKesson Corporation, HR Insights, Siemens Healthineers, Oracle Corporation, Allscripts Healthcare Solutions, Inc., Philips Healthcare, IQVIA, Flatiron Health and among others.

Key Developments

  • In May 2024, mPulse, a leader in conversational AI and digital engagement solutions for healthcare, reported strong growth in Q1 2024 compared to Q1 2023. The company also launched integrated predictive analytics and omnichannel engagement products, establishing a new category within the digital health ecosystem.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Healthcare Analytics market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Data-driven Decision Making in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. Data Privacy and Security Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Software*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Services

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Descriptive Analytics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Predictive Analytics
  • 7.4. Prescriptive Analytics

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Financial Analytics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinical Analytics
  • 8.4. Operational Analytics
  • 8.5. Population Health Analytics
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Payers (Insurance Companies)
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Government Organizations

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. IBM Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. SAS Institute Inc.
  • 12.3. McKesson Corporation
  • 12.4. HR Insights
  • 12.5. Siemens Healthineers
  • 12.6. Oracle Corporation
  • 12.7. Allscripts Healthcare Solutions, Inc.
  • 12.8. Philips Healthcare
  • 12.9. IQVIA
  • 12.10. Flatiron Health
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Health Catalyst*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. Verisk Analytics
  • 12.13. OmniSYS
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us